Highly elevated human epididymis protein 4 (HE4) following endometrioma rupture: a case report
- 7 March 2018
- journal article
- case report
- Published by Taylor & Francis in Journal of Obstetrics and Gynaecology
- Vol. 38 (6) , 885-886
Abstract
(2018). Highly elevated human epididymis protein 4 (HE4) following endometrioma rupture: a case report. Journal of Obstetrics and Gynaecology: Vol. 38, No. 6, pp. 885-886.Keywords
This publication has 8 references indexed in Scilit:
- Evaluation of HE4, CA-125, Risk of Ovarian Malignancy Algorithm (ROMA) and Risk of Malignancy Index (RMI) in the Preoperative Assessment of Patients with Adnexal MassOman Medical Journal, 2016
- Analysis of falsely elevated risk of ovarian malignancy algorithm in women with ovarian endometriomaObstetrics & Gynecology Science, 2016
- Comparison of ovarian cancer markers in endometriosis favours HE4 over CA125Molecular Medicine Reports, 2015
- Diagnostic accuracy of serum HE4, CA125 and ROMA in patients with ovarian cancer: a meta-analysisTumor Biology, 2014
- Serum HE4 levels are less frequently elevated than CA125 in women with benign gynecologic disordersAmerican Journal of Obstetrics and Gynecology, 2012
- Serum biomarker panels for the discrimination of benign from malignant cases in patients with an adnexal massGynecologic Oncology, 2010
- Comprehensive analysis of HE4 expression in normal and malignant human tissuesLaboratory Investigation, 2006
- Elevated serum CA125 and CA19-9 due to the spontaneous rupture of ovarian endometriomaEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2002